These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19670037)

  • 1. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic value of creatine kinase-myocardial band mass after cardiac surgery in low-risk patients with stable angina.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Cardiology; 2009; 113(2):122-31. PubMed ID: 19039220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.
    Vikenes K; Andersen KS; Melberg T; Farstad M; Nordrehaug JE
    Am J Cardiol; 2010 Sep; 106(6):780-6. PubMed ID: 20816117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of CK-MB and the troponins after angioplasty in patients with stable angina.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2011 Jun; 45(3):146-52. PubMed ID: 21413871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.
    Pasceri V; Patti G; Nusca A; Pristipino C; Richichi G; Di Sciascio G;
    Circulation; 2004 Aug; 110(6):674-8. PubMed ID: 15277322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.
    Kouvelos GN; Milionis HJ; Arnaoutoglou EM; Chasiotis G; Gartzonika C; Papa NK; Tzimas P; Matsagkas MI
    Coron Artery Dis; 2011; 22(6):428-34. PubMed ID: 21730823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk.
    Rademacher W; Knape A; Schumm J; Ferrari M; Lauten A; Mudra H; Figulla HR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):871-7. PubMed ID: 18603543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after surgery for acute coronary syndromes in relation to perioperative troponin T release and angina class - a prospective study in 200 patients.
    Bjessmo S; Svenarud P; Tran PK
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):148-52. PubMed ID: 19330751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
    Yan AT; Yan RT; Tan M; Chow CM; Fitchett D; Stanton E; Langer A; Goodman SG;
    Eur Heart J; 2004 Nov; 25(22):2006-12. PubMed ID: 15541836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic and prognostic value of atherosclerosis risk factors for predicting 1 year outcome in patients with acute myocardial infarction and in patients with stable coronary artery disease receiving percutaneous transluminal coronary angioplasty].
    Drobniak-Hełdak D; Kolasińska-Kloch W; Rajtar-Salwa R
    Folia Med Cracov; 2009; 50(3-4):43-54. PubMed ID: 21853870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
    Galla JM; Mahaffey KW; Sapp SK; Alexander JH; Roe MT; Ohman EM; Granger CB; Armstrong PW; Harrington RA; White HD; Simoons ML; Newby LK; Califf RM; Topol EJ
    Am Heart J; 2006 Jan; 151(1):16-24. PubMed ID: 16368286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists.
    Mark B; Schneider S; Schiele R; Taubert G; Kilkowski C; Seidl K; Nagel D; Seiler D; Senges J; Zahn R
    Z Kardiol; 2003 Dec; 92(12):1018-24. PubMed ID: 14663612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I.
    Bar-Or D; Winkler JV; Vanbenthuysen K; Harris L; Lau E; Hetzel FW
    Am Heart J; 2001 Jun; 141(6):985-91. PubMed ID: 11376314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.